- Home
- MAMA vs JSPR Comparison
MAMA vs JSPR Comparison
Compare MAMA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- JSPR
- Stock Information
- Founded
- MAMA 2010
- JSPR 2018
- Country
- MAMA United States
- JSPR United States
- Employees
- MAMA N/A
- JSPR N/A
- Industry
- MAMA Specialty Foods
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAMA Consumer Staples
- JSPR Health Care
- Exchange
- MAMA Nasdaq
- JSPR Nasdaq
- Market Cap
- MAMA 290.7M
- JSPR 325.7M
- IPO Year
- MAMA N/A
- JSPR N/A
- Fundamental
- Price
- MAMA $7.56
- JSPR $21.71
- Analyst Decision
- MAMA Strong Buy
- JSPR Strong Buy
- Analyst Count
- MAMA 4
- JSPR 11
- Target Price
- MAMA $10.50
- JSPR $73.38
- AVG Volume (30 Days)
- MAMA 483.1K
- JSPR 184.2K
- Earning Date
- MAMA 12-16-2024
- JSPR 11-07-2024
- Dividend Yield
- MAMA N/A
- JSPR N/A
- EPS Growth
- MAMA N/A
- JSPR N/A
- EPS
- MAMA 0.08
- JSPR N/A
- Revenue
- MAMA $116,468,000.00
- JSPR N/A
- Revenue This Year
- MAMA $18.91
- JSPR N/A
- Revenue Next Year
- MAMA $12.69
- JSPR N/A
- P/E Ratio
- MAMA $89.73
- JSPR N/A
- Revenue Growth
- MAMA 17.20
- JSPR N/A
- 52 Week Low
- MAMA $4.17
- JSPR $5.02
- 52 Week High
- MAMA $9.98
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- MAMA 34.45
- JSPR 49.34
- Support Level
- MAMA $7.19
- JSPR $20.77
- Resistance Level
- MAMA $9.83
- JSPR $23.11
- Average True Range (ATR)
- MAMA 0.55
- JSPR 1.67
- MACD
- MAMA -0.28
- JSPR -0.08
- Stochastic Oscillator
- MAMA 13.26
- JSPR 51.34
About MAMA Mama's Creations Inc.
Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.